GlassScriptPhysician profile
Jenell Coleman
NPI 1104803386
$18,189.17
in general payments reported to CMS, 2019-2025
7 companies · $9,168 in 2025
The $9,168 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.78 · 2020: $1,128 · 2023: $3,268 · 2024: $4,525 · 2025: $9,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $1,222 · Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,557.50 |
| Travel and Lodging | $1,221.71 |
| Food and Beverage | $182.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $9,168.23 | 2025 | Yeztugo |
| Viiv Healthcare Company | $3,250.00 | 2023 | Apretude |
| Gen-Probe, INC. | $2,546.08 | 2024 | Aptima |
| Merck Sharp & Dohme LLC | $1,627.50 | 2024 | |
| Lupin INC. | $1,227.78 | 2019-2020 | |
| Hologic Sales and Service, LLC | $351.41 | 2024 | Aptima |
| Ethicon US, LLC | $18.17 | 2023 | Enseal X1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenell Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.